Autism Spectrum Disorder (ASD)NCT07597681
Children With Autism and Social Interaction Processing
An observational study of Autism Spectrum Disorder (ASD), run by University of Electronic Science and Technology of China at 1 site in China.
Trial summary
Attention allocation in ASD vs. TD children viewing social/non-social interactions by adult/child models, and the dynamics of social attention. Read more about this study
- Who is it for?
- Ages 3 to 9 yearsHealthy volunteers can take part
- Conditions the study is for
- Autism Spectrum Disorder (ASD)
- How many people
- 59 participants
- Where
- 1 siteChina
- Study dates
- 28 Dec 2024to 12 Oct 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 9 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: In this experiment, 47 children with autism spectrum disorder (ASD) were recruited from an autism rehabilitation institution in Chengdu, and 37 typically developing (TD) children were recruited from a kindergarten in Shehong City. All ASD participants were clinically diagnosed with ASD by hospital physicians according to the DSM-5 criteria. Each participant underwent SRS,AQ,and SCQ tests.
Who may be able to join
- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder(DSM-5/ADOS-2) For TD group：TD children without any developmental or neurological disorders Both groups：Normal or corrected-to-normal vision，no color vision deficiencies，and legal guardian provided written informed consent
Who cannot join
- TD group: meet the study's group-specific screening cutoffs on SRS, SCQ or AQ ASD group：Failure to meet the study's group-specific screening cutoffs on ADOS-2 Both groups：Known genetic syndromes，significant hearing loss or uncorrectable visual impairment
Trial locations and contacts
1 site in 1 country.
China1 site
School of Foreign Languages, University of Electronic Science and Technology of China
Chengdu, Sichuan, 611731
About this study
Official title: Characteristics of Gaze Behavior in Social Interaction Processing of Children With Autism
Attention allocation in ASD vs. TD children viewing social/non-social interactions by adult/child models, and the dynamics of social attention.
Read the detailed description
Participants: ASD group: 30 children; TD group: 29 children; age- and sex-matched.
Apparatus: Non-invasive eye tracker (Tobii Pro Spectrum). Stimuli: Eight 60-second videos (4 with child models, 4 with adult models). Questionnaires/Assessments: SRS, AQ, SCQ, ADOS-2, PPVT. Experimental design: A 2 (group: TD, ASD) × 2 (model type: adult, child) × 2 (context: interactive, non-interactive) × 2 (phase: baseline, test) mixed design.
Task: Free viewing of eight videos presented in random order.
- Conditions
- Autism Spectrum Disorder (ASD)
- Keywords
- Own-age bias, Joint attention, Temporal Dynamic, ASD
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Autism Spectrum Disorder (ASD) Group | Not described | |
| Typically Developing (TD) Group | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of total fixation duration on human faces, context, activity areas
Proportion of total fiaxtion duration on human faces, context, activity areas was calculated as (total fixation duration on AOIs/ total fixation duration on the screen).
Measured: During the full 8 minutes video presentation
Number of saccades on human faces, context, activity areas
The number of saccades on human faces, context, activity areas occurring during an interval.
Measured: During the full 8 minutes video presentation
Social Prioritization Score on human faces, context, activity areas
The difference in the proportion of fixation time between social and non-social interaction information.
Measured: During the full 8 minutes video presentation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2026
- Study start28 Dec 2024
- Primary completion23 Mar 2025
- Study completion12 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism Spectrum Disorder (ASD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 59 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Electronic Science and Technology of China
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shan Gao, University of Electronic Science and Technology of China
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07597681
- Sponsor's protocol ID
- UESTC-GazeLab-05
- Status last verified
- May 2026
- First submitted
- 6 May 2026
- Last updated
- 19 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Characteristics of Gaze Behavior in Social Interaction Processing of Children With Autism
- ClinicalTrials.gov ID
- NCT07597681
- Acronym / sponsor ID
- UESTC-GazeLab-05
- Conditions
- Autism Spectrum Disorder (ASD)
- Keywords
- Own-age bias, Joint attention, Temporal Dynamic, ASD
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 59 participants (actual)
- Lead sponsor
- University of Electronic Science and Technology of ChinaUniversity, hospital or other
- Study start
- 28 Dec 2024 (actual)
- Primary completion
- 23 Mar 2025 (actual)
- Study completion
- 12 Oct 2025 (actual)
- First posted
- 19 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Attention allocation in ASD vs. TD children viewing social/non-social interactions by adult/child models, and the dynamics of social attention.
Detailed description
Participants: ASD group: 30 children; TD group: 29 children; age- and sex-matched.
Apparatus: Non-invasive eye tracker (Tobii Pro Spectrum). Stimuli: Eight 60-second videos (4 with child models, 4 with adult models). Questionnaires/Assessments: SRS, AQ, SCQ, ADOS-2, PPVT. Experimental design: A 2 (group: TD, ASD) × 2 (model type: adult, child) × 2 (context: interactive, non-interactive) × 2 (phase: baseline, test) mixed design.
Task: Free viewing of eight videos presented in random order.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Autism Spectrum Disorder (ASD) Group | – | – |
| Typically Developing (TD) Group | – | – |
Who may qualify
- Ages
- 3 to 9 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- In this experiment, 47 children with autism spectrum disorder (ASD) were recruited from an autism rehabilitation institution in Chengdu, and 37 typically developing (TD) children were recruited from a kindergarten in Shehong City. All ASD participants were clinically diagnosed with ASD by hospital physicians according to the DSM-5 criteria. Each participant underwent SRS,AQ,and SCQ tests.
Key inclusion criteria (1 listed)
- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder(DSM-5/ADOS-2) For TD group：TD children without any developmental or neurological disorders Both groups：Normal or corrected-to-normal vision，no color vision deficiencies，and legal guardian provided written informed consent
Key exclusion criteria (1 listed)
- TD group: meet the study's group-specific screening cutoffs on SRS, SCQ or AQ ASD group：Failure to meet the study's group-specific screening cutoffs on ADOS-2 Both groups：Known genetic syndromes，significant hearing loss or uncorrectable visual impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Proportion of total fixation duration on human faces, context, activity areas
Time frame: During the full 8 minutes video presentation
Proportion of total fiaxtion duration on human faces, context, activity areas was calculated as (total fixation duration on AOIs/ total fixation duration on the screen).
Number of saccades on human faces, context, activity areas
Time frame: During the full 8 minutes video presentation
The number of saccades on human faces, context, activity areas occurring during an interval.
Social Prioritization Score on human faces, context, activity areas
Time frame: During the full 8 minutes video presentation
The difference in the proportion of fixation time between social and non-social interaction information.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Autism Spectrum Disorder (ASD)
Not yet recruiting
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD)
Not yet recruiting
Evaluation of a Novel Quantum-Inspired Intervention (QII) for Children With Autism Spectrum Disorder: A Global Confirmatory Study
Autism Spectrum Disorder, Autism Spectrum Disorder (ASD
Recruiting
Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD
Autism Spectrum Disorder, Therapy
Recruiting
Smith Magenis Syndrome and Autism Spectrum Disorders
Smith-Magenis Syndrome, Autism Spectrum Disorder
Active, not recruitingPhase 1
Psilocybin for Treatment-Resistant Depression in Autism
Treatment Resistant Depression, Autism Spectrum Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Autism Spectrum Disorder (ASD), run by University of Electronic Science and Technology of China at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of total fixation duration on human faces, context, activity areas (time frame: During the full 8 minutes video presentation). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.